We measure the odds ratio of developing pancreatitis between patients who have taken a large cumulative dose of GLP-1 agonist and those with a low cumulative dose of GLP-1 agonist
This isnt a failing of the medicinesit reflects the nature of obesity as a chronic, relapsing condition
Combination Therapies: PLE enhances outcomes when paired with other treatments
Because experimental outcomes depend on model design, concentration selection, solvent system, controls, storage history, and analytical endpoints, all conclusions should be drawn only within the limits of the laboratory protocol
These supplements may not be safe to take with certain medications, including those used to treat chest pain.
CMS is aiming for robust Part D plan participation in the BALANCE model, which is voluntary for plans, but this is still uncertain